GLP-1 weight regain after stopping: what the data shows

What did @drjonesdc actually say?

The creator, who identifies as a DC (doctor of chiropractic), claims that weight creeping back after GLP-1 therapy can be stopped by improving "metabolic health" through low-carb eating for three to six months combined with extended fasting. The logic: become more insulin sensitive, reduce inflammation, and you lower your body's weight "set point" permanently. He also mentions AOD 9604, a peptide, as something that makes fasting easier alongside GLP-1 medications.

The core pitch is that strategic longer fasting periods on non-fasting days will make weight maintenance "a breeze." That's a strong promise. Let's see what the evidence actually supports.

Does the science back this up?

Partially, yes, but with important caveats. The evidence for low-carbohydrate diets improving insulin sensitivity is real. A 2022 trial by Ebbeling et al. in the American Journal of Clinical Nutrition found that low-carb diets increased energy expenditure and improved metabolic markers in adults with overweight. That part holds up.

The set point language is where things get slippery. "Set point" is a popular concept, but the more accurate term researchers use is "defended body weight," which reflects biological adaptations including changes in leptin, ghrelin, and thyroid hormones after weight loss. A landmark 2011 study by Sumithran et al. in the New England Journal of Medicine showed these hormonal adaptations persist for at least a year after weight loss, driving hunger and regain. The claim that fasting can permanently "lower" this defended weight is speculative. There is no robust long-term human trial proving extended fasting resets set point biology in a durable way.

Intermittent fasting does show metabolic benefits in short-term trials. A 2020 review by de Cabo and Mattson in the New England Journal of Medicine found improvements in insulin sensitivity, blood pressure, and inflammation markers. But "breeze" is doing a lot of heavy lifting here.

What did they get wrong (or right)?

Credit where it is due: the general direction of the advice, eat less ultra-processed food, reduce carbohydrate load, incorporate fasting, is supported by evidence for metabolic improvement. These are not fringe ideas.

What is more problematic is the AOD 9604 mention. AOD 9604 is a synthetic peptide fragment derived from human growth hormone. The FDA has not approved it for any indication. It has not completed Phase III clinical trials for weight management. The creator slips it in casually, implying it works synergistically with GLP-1s to make fasting easier. There is no peer-reviewed clinical evidence supporting that claim in humans. Recommending unregulated peptides to a 22,000-person audience without that context is irresponsible, regardless of how it was framed.

The "set point" framing is also oversimplified to the point of being misleading. Suggesting that dietary changes alone can permanently eliminate biological weight defense mechanisms sets up patients for guilt when regain happens anyway, which data shows it often does after GLP-1 discontinuation regardless of lifestyle habits.

What should you actually know?

Weight regain after GLP-1 discontinuation is not a personal failure, it is a documented pharmacological reality. The 2022 STEP 4 trial published in JAMA showed that participants who stopped semaglutide regained two-thirds of their lost weight within one year, even with continued lifestyle intervention. The medication is doing significant biological work that diet alone cannot fully replicate once it is gone.

That does not mean lifestyle changes are useless. Resistance training, specifically preserving muscle mass during GLP-1 therapy, is one of the strongest evidence-backed strategies for improving long-term metabolic outcomes and slowing regain. A 2023 paper by Lundgren et al. in Obesity emphasized that muscle mass preservation during GLP-1 treatment substantially affects resting metabolic rate after cessation.

If you are experiencing weight creep after GLP-1 therapy, the conversation should start with your prescribing clinician, not a TikTok algorithm. Dose adjustments, medication switches, or structured lifestyle programs supervised by a registered dietitian all carry more evidence than a fasting protocol promoted by a chiropractor on social media.

Bottom line: worth watching or worth skipping?

The lifestyle direction is reasonable. The set point language is oversimplified. The AOD 9604 mention is a red flag that should make anyone pause. A chiropractor coaching "thousands of patients on GLP-1s every single day" is also a credential claim worth scrutinizing. Chiropractors are not licensed to prescribe medications in any U.S. state. How that coaching relationship works legally is a question this video does not answer. Take the general dietary advice with some merit, and leave the peptide recommendations alone until there is actual clinical evidence to support them.